• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Govt aims to raise API production to cut Chinese dependence

expressbpdOctober 11, 2018

Tag: china , API

The government is working on a road map to increase production of bulk drugs in the country with a view to reduce import dependence of the raw materials for pharma sector from China, a commerce ministry report said.

 

Previous:Agios receives nod for ivosidenib

Next:Allergan works toward blockbuster goal with new CoolSculpting OK

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Govt aims to raise API production to cut Chinese dependence | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Vitamin D3 ≥90.0% Vitamins Food Additive made in china

Vitamin D3 ≥90.0% Vitamins Food Additive made in china
8-Hydroxyapigenin

8-Hydroxyapigenin
Quetiapine Fumarate

Quetiapine Fumarate
Isepamicine ≥98.0% API Antibiotics made in china

Isepamicine ≥98.0% API Antibiotics made in china
CLOZAPINE

CLOZAPINE
Quetiapine

Quetiapine
Fosfomycin calcium CP/EP ≥98.0% Pharmaceutical API made in china

Fosfomycin calcium CP/EP ≥98.0% Pharmaceutical API made in china
Ibandronate Cas 114084-78-5 from China

Ibandronate Cas 114084-78-5 from China
ANTI-EAPII (TTRAP)

ANTI-EAPII (TTRAP)
Echinacea Angustifolia Extract Powder 4%HPLC

Echinacea Angustifolia Extract Powder 4%HPLC

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service